EGFR and glioblastoma: Mutational profiles of GBM-INO-1 and GBM-INO-2 showed that GBMs with the majority of the TP53 and EGFR mutations belonged to the INO-2 subgroup, in which we also reported higher presence (> 70% GBMs) of mutations within TTN gene.